Public/Private Partnerships Keep Gonorrhea Drug Development Alive

Only two new antibiotics are in Phase III trials for gonorrhea: Entasis’ zoliflodacin, in collaboration with the Global Antibiotic R&D Partnership, and GlaxoSmithKline’s gepotidacin in partnership with the US Biomedical Advanced R&D Authority.

Gonorrhea blood test tube positive sample. Alamy - 2CCG4AH — • Source: Alamy

The next drug for gonorrhea will probably come from a public/private partnership, a recent workshop sponsored by the US Food and Drug Administration suggested.

“Almost all development is being done on public money,” Sue Cammarata, a senior clinical subject matter expert consultant with Tunnell...